Results of selective venous catheterization (SVC) in occult medullary thyroid carcinoma;ERGEBNISSE DES SELEKTIVEN VENOSEN ETAGENKATHETERS (SVK) BEIM OKKULTEN C-ZELL-KARZINOM DER SCHILDDRUSE

Langenbecks Archiv fur Chirurgie

Volumn 382, Issue 6, 1997, Pages 295-301

  Cupisti, K ^a   Simon, D ^a   Goretzki, Cornelia Dotzenrath P E ^a   Roher H D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Calcitonin; Localization; Medullary thyroid carcinoma; Selective venous catheterization

Indexed keywords

CALCITONIN; HORMONE;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MORTALITY; REOPERATION; THYROID MEDULLARY CARCINOMA; TUMOR RECURRENCE; VEIN CATHETERIZATION; ADOLESCENT; BLOOD; FOLLOW UP; INDWELLING CATHETER; MEDULLARY CARCINOMA; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; PATHOLOGY; RETROSPECTIVE STUDY; THYROID TUMOR; THYROIDECTOMY; VEIN;

ADOLESCENT; ADULT; CALCITONIN; CARCINOMA, MEDULLARY; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; HORMONES, ECTOPIC; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM, RESIDUAL; REOPERATION; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; VEINS;

EID: 0031469351     PISSN: 00238236     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050070     Document Type: Article

References (13)

1. Abdelmoumene N, Schlumberger M, Gardet P, Roche A, Travagli JP, Francese C, Parmentier C (1994) Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 69: 1141-1144
2. Gautvik KM, Norman T, Teig V, Wille SÖ, Brennhovd IO, Christensen I (1976) Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland. Scand J Clin Lab Invest 36: 323-329
3. Goltzman D, Potts JT Jr, Ridgway EC, Maloof F (1974) Calcitonin as a tumor marker. N Engl J Med 290: 1035
4. Grauer A, Raue F, Gagel RF (1990) Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 613-635
5. Melvin KEW, Miller HH, Tashjian AH Jr (197.1) Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med 285: 1115
6. Moley JF, Wells SA, Dilley WG, Tisell LE (1993) Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114: 1090-1096
7. Mrad MDB, Gardet P, Roche A, Rougier Ph, Calmettes C, Motte Ph, Parmentier C (1989) Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma. Cancer 63: 133-138
8. Norton JA, Doppman JL, Brennan MF (1980) Localization and resection of clinically inapparent medullary carcinoma of the thyroid. Surgery 87: 616-622
9. Reiners Ch, Schramm A (1981) Nachsorge des C-Zell-Karinoms der Schilddrüse. Munch Med Wochenschr 123: 1708-1710
10. Röher HD (1987) Endokrine Chirurgie. Thieme, Stuttgart New York, S 20 f
11. Tisell LE, Dilley WG, Wells SA (1996) Progression of post-operative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 119: 34-39
12. Tisell LE, Hansson G, Jansson S, Salander H (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99: 60-66
13. Tung WS, Vesely TM, Moley JF (1995) Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery 118: 1024-1030